Exchange: NASDAQ·Updated 04:51 AM EDT

ABVX News

News
all
press releases
These Analysts Slash Their Forecasts On Abivax Following H1 Results
Abivax missed EPS estimates but beat sales in H1; shares dipped. Wedbush and Truist cut price targets to $118 and $151.read more...
Benzinga
More News
Earnings Scheduled For September 21, 2026
Companies Reporting Before The Bell Ennis (NYSE:EBF) is expected to report earnings for its second quarter. Companies Reporting After The Bell Abivax (NASDAQ:ABVX) is projected to report quarterly loss at $1.08 perread more...
Benzinga
Accenture, Abivax and 3 Stocks to Watch Heading Into Monday
Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.read more...
Benzinga
4 Biotech Stocks to Watch as Potential Takeover Targets
Biotech M&A surges in 2026, putting ABVX, IOVA, VKTX and BCRX on watchlists, as drugmakers seek late-stage and commercial assets.
Zacks
Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Abivax will report H1 earnings Sept. 21; analysts expect a $1.08 loss/share and $1.86M revenue.read more...
Benzinga
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why
Abivax SA Sponsored ADR (ABVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Zacks
ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds
Abivax said underwriters have fully exercised their option to purchase an additional 960,000 American depositary shares as part of their $920 million offering.
Stocktwits
Abivax Prices $800M Offering Of ADS – Here’s A Look At Some Key Figures
The size of the offering was increased to $800 million from the previously announced offering of $600 million in ADSs.
Stocktwits
ABIVAX Announces Pricing Of $800 Mln Offering Of ADS
(RTTNews) - Wednesday, ABIVAX Soci?t? Anonyme (ABVX) announced the pricing of an underwritten public offering of 6.4 million American Depositary Shares or ADSs, each representing one ordinary share, 0.01 nominal value per share, of the company, for $125 per ADS...
Nasdaq News: Markets

Advertisement|Remove ads.